Pulmonx (LUNG) Interest Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Interest Expenses data on file, last reported at $805000.0 in Q3 2025.

• On a quarterly basis, Interest Expenses fell 10.56% year-over-year to $805000.0 in Q3 2025; TTM through Dec 2025 was $2.4 million, a 30.93% decrease from a year earlier, with the FY2024 full-year figure at $4.5 million, down 94.37% from the prior year.
• Interest Expenses for Q3 2025 stood at $805000.0, down from $31.0 million in the prior quarter.
• Over the last five years, Interest Expenses for LUNG reached as high as $31.0 million in Q2 2025 and fell as low as -$975000.0 in Q4 2022.
• Historically, Interest Expenses has averaged $2.1 million across 5 years, with a median of $805000.0 in 2025.
• Across the five-year window, Interest Expenses slumped 529.52% in 2022 and jumped 3383.39% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $227000.0 in 2021, then slumped by 529.52% to -$975000.0 in 2022, then soared by 194.15% to $918000.0 in 2023, then retreated by 8.28% to $842000.0 in 2024, then dropped by 4.39% to $805000.0 in 2025.
• Per Business Quant data, the three most recent Interest Expenses figures were $805000.0 in Q3 2025, $31.0 million in Q2 2025, and $800000.0 in Q1 2025.